E-cadherin and α-, β- and γ-catenin expression in prostate cancers: correlation with tumour invasion

[1]  C. Smart.  The results of prostate carcinoma screening in the U. S. As reflected in the surveillance, epidemiology, and end results program , 1997 .

[2]  W. Isaacs,et al.  Relation between aberrant α‐catenin expression and loss of E‐cadherin function in prostate cancer , 1997, International journal of cancer.

[3]  A. Nagafuchi,et al.  Aberrant E-cadherin and alpha-catenin expression in prostate cancer: correlation with patient survival. , 1997, Cancer research.

[4]  G Brabant,et al.  Immunohistochemical detection of E-cadherin in differentiated thyroid carcinomas correlates with clinical outcome. , 1997, Cancer research.

[5]  D M Parkin,et al.  Cancer incidence and mortality in the European Union: cancer registry data and estimates of national incidence for 1990. , 1997, European journal of cancer.

[6]  Yusuke Nakamura.  Cleaning up on β-catenin , 1997, Nature Medicine.

[7]  K. Kinzler,et al.  Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC−/− Colon Carcinoma , 1997, Science.

[8]  Hans Clevers,et al.  Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC , 1997, Science.

[9]  J. Schalken,et al.  Prognostic value of cadherin-associated molecules (alpha-, beta-, and gamma-catenins and p120cas) in bladder tumors. , 1996, Cancer research.

[10]  S. Hirohashi,et al.  Dominant negative inhibition of the association between beta-catenin and c-erbB-2 by N-terminally deleted beta-catenin suppresses the invasion and metastasis of cancer cells. , 1996, Oncogene.

[11]  J. Kononen,et al.  Reduced E-cadherin expression is associated with invasiveness and unfavorable prognosis in breast cancer. , 1996, American journal of clinical pathology.

[12]  K. Syrigos,et al.  E‐cadherin expression in bladder cancer using formalin‐fixed, paraffin‐embedded tissues: Correlation with histopathological grade, tumour stage and survival , 1995, International journal of cancer.

[13]  W. Pierceall,et al.  Frequent alterations in E-cadherin and alpha- and beta-catenin expression in human breast cancer cell lines. , 1995, Oncogene.

[14]  P. Troncoso,et al.  c-met proto-oncogene expression in benign and malignant human prostate tissues. , 1995, The Journal of urology.

[15]  J. S. Morrow,et al.  Reduced alpha-catenin and E-cadherin expression in breast cancer. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[16]  K. Green,et al.  Posttranslational regulation of plakoglobin expression. Influence of the desmosomal cadherins on plakoglobin metabolic stability. , 1994, The Journal of biological chemistry.

[17]  W. Isaacs,et al.  Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer. , 1994, Cancer research.

[18]  J. Papkoff,et al.  Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly , 1994, The Journal of cell biology.

[19]  S. Hirohashi,et al.  Frequent Loss of α Catenin Expression in Scirrhous Carcinomas with Scattered Cell Growth , 1994, Japanese journal of cancer research : Gann.

[20]  J. Schalken,et al.  Decreased expression of E-cadherin in the progression of rat prostatic cancer. , 1992, Cancer research.

[21]  W. Fiers,et al.  Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.

[22]  M. Takeichi,et al.  The 102 kd cadherin-associated protein: Similarity to vinculin and posttranscriptional regulation of expression , 1991, Cell.

[23]  M. Takeichi,et al.  Cadherin cell adhesion receptors as a morphogenetic regulator. , 1991, Science.

[24]  W. Birchmeier,et al.  Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cell-cell adhesion , 1989, The Journal of cell biology.

[25]  R. Kemler,et al.  The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. , 1989, The EMBO journal.

[26]  T. Kuroishi,et al.  An ecological study on diet/nutrition and cancer in Japan , 1997, International journal of cancer.

[27]  S. Jordan,et al.  Abnormal immunoreactivity of the E-cadherin-catenin complex in gastric carcinoma: relationship with patient survival. , 1997, Gastroenterology.

[28]  R. Hall.  Screening and early detection of prostate cancer will decrease morbidity and mortality from prostate cancer: the argument against. , 1996, European urology.

[29]  Y. Doki,et al.  E-Cadherin and α-Catenin Expression in Human Esophageal Cancer , 1994 .

[30]  T. Tong,et al.  Cancer statistics, 1993 , 1993, CA: a cancer journal for clinicians.

[31]  D. Assimos,et al.  Prognostic significance of tumor grade and stage in the patient with carcinoma of the prostate , 1983, The Prostate.